Advertisement
Advertisement

DYN

DYN logo

Dyne Therapeutics, Inc. Common Stock

16.80
USD
Sponsored
+0.25
+1.50%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

17.04

+0.24
+1.40%

DYN Earnings Reports

Positive Surprise Ratio

DYN beat 7 of 21 last estimates.

33%

Next Report

Date of Next Report
Feb 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.77
Implied change from Q3 25 (Revenue/ EPS)
--
/
+1.32%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-12.50%

Dyne Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 05, 2025, DYN reported earnings of -0.76 USD per share (EPS) for Q3 25, beating the estimate of -0.84 USD, resulting in a 10.13% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.89% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analysts forecast an EPS of -0.77 USD, with revenue projected to reach -- USD, implying an increase of 1.32% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Dyne Therapeutics, Inc. Common Stock reported EPS of -$0.76, beating estimates by 10.13%, and revenue of $0.00, 0% as expectations.
The stock price moved down -12.89%, changed from $20.90 before the earnings release to $18.20 the day after.
The next earning report is scheduled for Feb 26, 2026.
Based on 17 analysts, Dyne Therapeutics, Inc. Common Stock is expected to report EPS of -$0.77 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement